VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Half the World Infected with H. pylori: Novel Dual-Target Drug Rifasutenizol Shows 92% Eradication Rate
Half the World Infected with H. pylori: Novel Dual-Target Drug Rifasutenizol Shows 92% Eradication Rate
Jun 12, 2026 13:45 CST Updated 15:47
Share: